Biologic Prophylaxis Reduces Postoperative Recurrence in Crohn’s Disease

The effect of biologic therapy in reducing risks of recurrence following surgery for Crohn’s disease was observed across patient subgroups, suggesting broad benefit regardless of individual risk profile, researchers reported.